Skip to main content
Clinical Trials/NCT04839835
NCT04839835UnknownNot Applicable

The Effect of Art Design in the Chemotherapy Waiting Room on the Anxiety of Patients Who Will Receive Chemotherapy for the First Time

Namik Kemal University2 sites in 1 country106 target enrollmentStarted: November 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
106
Locations
2
Primary Endpoint
anxiety and stress measurements

Study Overview

Brief Summary

investigating chemotherapy anxieties

Detailed Description

Breast cancer is the most common type of cancer in women in the world, and it is the first in cancer-related deaths in women all over the world. In the treatment of breast cancer, in addition to surgery, patients with advanced stage or high risk of recurrence receive neoadjuvant and adjuvant chemotherapy treatments. This period starts with 3 months and extends according to the treatment protocols it will receive.

Since the first diagnosis of breast cancer, it has psychological effects such as intense stress, decrease in quality of life and anxiety as well as physical effects on patients. The time spent in the "waiting room" while patients are examined and receiving treatment before chemotherapy inevitably has an effect on their anxiety.

In this study; It was aimed to investigate the effects of environmental factors in waiting rooms on patients' anxiety.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • to receive chemotherapy for breast cancer for the first time
  • give consent for the study

Exclusion Criteria

  • not approving to participate in the study

Outcomes

Primary Outcomes

anxiety and stress measurements

Time Frame: 60-120 minutes

The State-Trait Anxiety Inventory (STAI) - Measuring anxiety with the Hospital Anxiety and Depression Scale (HADS)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Namik Kemal University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Asoc. Prof. Erdoğan Selçuk Şeber

Asoc. Prof.

Namik Kemal University

Study Sites (2)

Loading locations...

Similar Trials